CGS vs SPL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

58MEDIUM

SPL

STARPHARMA FPO [SPL]

58MEDIUM

Score Breakdown

CGS SPL
Technical
47
72
Catalyst
53
58
Sentiment
50
50
Fundamental
96
80
Momentum
79
80
Risk Gate
50
50

Key Metrics

CGS Metric SPL
$489.3MMarket Cap$315.7M
397KAvg Volume (20d)794K
+0.1%Short Interest+0.1%
$3.01052-Week High$0.790
$1.55052-Week Low$0.094
-3.5%Daily Change+5.1%
$2.780Entry Price$0.767
+22.5%ROE-14.5%
+19.2%Profit Margin-22.2%

Active Signals

CGS Signals

●MACD crossed bearish — momentum is fading
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.7x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

SPL Signals

●MACD momentum is picking up steam
●Pressing against the upper Bollinger Band — extended and may need to cool off
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Knocking on the door of resistance — if it punches through, things could get interesting
●Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)

Ask Scout AI to compare CGS and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CGS Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).